Replication and meta-analysis of TMEM132D gene variants in panic disorder

A. Erhardt, N. Akula, J. Schumacher, D. Czamara, N. Karbalai, B. Müller-Myhsok, O. Mors, A. Borglum, A. S. Kristensen, D. P D Woldbye, P. Koefoed, E. Eriksson, E. Maron, A. Metspalu, John Nurnberger, R. A. Philibert, J. Kennedy, K. Domschke, A. Reif, J. DeckertT. Otowa, Y. Kawamura, H. Kaiya, Y. Okazaki, H. Tanii, K. Tokunaga, T. Sasaki, J. P A Ioannidis, F. J. McMahon, E. B. Binder

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

A recent genome-wide association study in patients with panic disorder (PD) identified a risk haplotype consisting of two single-nucleotide polymorphisms (SNPs) (rs7309727 and rs11060369) located in intron 3 of TMEM132D to be associated with PD in three independent samples. Now we report a subsequent confirmation study using five additional PD case-control samples (n1670 cases and n2266 controls) assembled as part of the Panic Disorder International Consortium (PanIC) study for a total of 2678 cases and 3262 controls in the analysis. In the new independent samples of European ancestry (EA), the association of rs7309727 and the risk haplotype rs7309727-rs11060369 was, indeed, replicated, with the strongest signal coming from patients with primary PD, that is, patients without major psychiatric comorbidities (n1038 cases and n2411 controls). This finding was paralleled by the results of the meta-analysis across all samples, in which the risk haplotype and rs7309727 reached P-levels of P1.4e8 and P1.1e8, respectively, when restricting the samples to individuals of EA with primary PD. In the Japanese sample no associations with PD could be found. The present results support the initial finding that TMEM132D gene contributes to genetic susceptibility for PD in individuals of EA. Our results also indicate that patient ascertainment and genetic background could be important sources of heterogeneity modifying this association signal in different populations.

Original languageEnglish
Article numbere156
JournalTranslational Psychiatry
Volume2
DOIs
StatePublished - 2012

Fingerprint

Panic Disorder
Meta-Analysis
Genes
Haplotypes
Genome-Wide Association Study
Genetic Predisposition to Disease
Introns
Single Nucleotide Polymorphism
Psychiatry
Comorbidity
Population

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Cellular and Molecular Neuroscience

Cite this

Erhardt, A., Akula, N., Schumacher, J., Czamara, D., Karbalai, N., Müller-Myhsok, B., ... Binder, E. B. (2012). Replication and meta-analysis of TMEM132D gene variants in panic disorder. Translational Psychiatry, 2, [e156]. https://doi.org/10.1038/tp.2012.85

Replication and meta-analysis of TMEM132D gene variants in panic disorder. / Erhardt, A.; Akula, N.; Schumacher, J.; Czamara, D.; Karbalai, N.; Müller-Myhsok, B.; Mors, O.; Borglum, A.; Kristensen, A. S.; Woldbye, D. P D; Koefoed, P.; Eriksson, E.; Maron, E.; Metspalu, A.; Nurnberger, John; Philibert, R. A.; Kennedy, J.; Domschke, K.; Reif, A.; Deckert, J.; Otowa, T.; Kawamura, Y.; Kaiya, H.; Okazaki, Y.; Tanii, H.; Tokunaga, K.; Sasaki, T.; Ioannidis, J. P A; McMahon, F. J.; Binder, E. B.

In: Translational Psychiatry, Vol. 2, e156, 2012.

Research output: Contribution to journalArticle

Erhardt, A, Akula, N, Schumacher, J, Czamara, D, Karbalai, N, Müller-Myhsok, B, Mors, O, Borglum, A, Kristensen, AS, Woldbye, DPD, Koefoed, P, Eriksson, E, Maron, E, Metspalu, A, Nurnberger, J, Philibert, RA, Kennedy, J, Domschke, K, Reif, A, Deckert, J, Otowa, T, Kawamura, Y, Kaiya, H, Okazaki, Y, Tanii, H, Tokunaga, K, Sasaki, T, Ioannidis, JPA, McMahon, FJ & Binder, EB 2012, 'Replication and meta-analysis of TMEM132D gene variants in panic disorder', Translational Psychiatry, vol. 2, e156. https://doi.org/10.1038/tp.2012.85
Erhardt A, Akula N, Schumacher J, Czamara D, Karbalai N, Müller-Myhsok B et al. Replication and meta-analysis of TMEM132D gene variants in panic disorder. Translational Psychiatry. 2012;2. e156. https://doi.org/10.1038/tp.2012.85
Erhardt, A. ; Akula, N. ; Schumacher, J. ; Czamara, D. ; Karbalai, N. ; Müller-Myhsok, B. ; Mors, O. ; Borglum, A. ; Kristensen, A. S. ; Woldbye, D. P D ; Koefoed, P. ; Eriksson, E. ; Maron, E. ; Metspalu, A. ; Nurnberger, John ; Philibert, R. A. ; Kennedy, J. ; Domschke, K. ; Reif, A. ; Deckert, J. ; Otowa, T. ; Kawamura, Y. ; Kaiya, H. ; Okazaki, Y. ; Tanii, H. ; Tokunaga, K. ; Sasaki, T. ; Ioannidis, J. P A ; McMahon, F. J. ; Binder, E. B. / Replication and meta-analysis of TMEM132D gene variants in panic disorder. In: Translational Psychiatry. 2012 ; Vol. 2.
@article{6bd96190d3404c519dc73d0916b0009f,
title = "Replication and meta-analysis of TMEM132D gene variants in panic disorder",
abstract = "A recent genome-wide association study in patients with panic disorder (PD) identified a risk haplotype consisting of two single-nucleotide polymorphisms (SNPs) (rs7309727 and rs11060369) located in intron 3 of TMEM132D to be associated with PD in three independent samples. Now we report a subsequent confirmation study using five additional PD case-control samples (n1670 cases and n2266 controls) assembled as part of the Panic Disorder International Consortium (PanIC) study for a total of 2678 cases and 3262 controls in the analysis. In the new independent samples of European ancestry (EA), the association of rs7309727 and the risk haplotype rs7309727-rs11060369 was, indeed, replicated, with the strongest signal coming from patients with primary PD, that is, patients without major psychiatric comorbidities (n1038 cases and n2411 controls). This finding was paralleled by the results of the meta-analysis across all samples, in which the risk haplotype and rs7309727 reached P-levels of P1.4e8 and P1.1e8, respectively, when restricting the samples to individuals of EA with primary PD. In the Japanese sample no associations with PD could be found. The present results support the initial finding that TMEM132D gene contributes to genetic susceptibility for PD in individuals of EA. Our results also indicate that patient ascertainment and genetic background could be important sources of heterogeneity modifying this association signal in different populations.",
author = "A. Erhardt and N. Akula and J. Schumacher and D. Czamara and N. Karbalai and B. M{\"u}ller-Myhsok and O. Mors and A. Borglum and Kristensen, {A. S.} and Woldbye, {D. P D} and P. Koefoed and E. Eriksson and E. Maron and A. Metspalu and John Nurnberger and Philibert, {R. A.} and J. Kennedy and K. Domschke and A. Reif and J. Deckert and T. Otowa and Y. Kawamura and H. Kaiya and Y. Okazaki and H. Tanii and K. Tokunaga and T. Sasaki and Ioannidis, {J. P A} and McMahon, {F. J.} and Binder, {E. B.}",
year = "2012",
doi = "10.1038/tp.2012.85",
language = "English",
volume = "2",
journal = "Translational Psychiatry",
issn = "2158-3188",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Replication and meta-analysis of TMEM132D gene variants in panic disorder

AU - Erhardt, A.

AU - Akula, N.

AU - Schumacher, J.

AU - Czamara, D.

AU - Karbalai, N.

AU - Müller-Myhsok, B.

AU - Mors, O.

AU - Borglum, A.

AU - Kristensen, A. S.

AU - Woldbye, D. P D

AU - Koefoed, P.

AU - Eriksson, E.

AU - Maron, E.

AU - Metspalu, A.

AU - Nurnberger, John

AU - Philibert, R. A.

AU - Kennedy, J.

AU - Domschke, K.

AU - Reif, A.

AU - Deckert, J.

AU - Otowa, T.

AU - Kawamura, Y.

AU - Kaiya, H.

AU - Okazaki, Y.

AU - Tanii, H.

AU - Tokunaga, K.

AU - Sasaki, T.

AU - Ioannidis, J. P A

AU - McMahon, F. J.

AU - Binder, E. B.

PY - 2012

Y1 - 2012

N2 - A recent genome-wide association study in patients with panic disorder (PD) identified a risk haplotype consisting of two single-nucleotide polymorphisms (SNPs) (rs7309727 and rs11060369) located in intron 3 of TMEM132D to be associated with PD in three independent samples. Now we report a subsequent confirmation study using five additional PD case-control samples (n1670 cases and n2266 controls) assembled as part of the Panic Disorder International Consortium (PanIC) study for a total of 2678 cases and 3262 controls in the analysis. In the new independent samples of European ancestry (EA), the association of rs7309727 and the risk haplotype rs7309727-rs11060369 was, indeed, replicated, with the strongest signal coming from patients with primary PD, that is, patients without major psychiatric comorbidities (n1038 cases and n2411 controls). This finding was paralleled by the results of the meta-analysis across all samples, in which the risk haplotype and rs7309727 reached P-levels of P1.4e8 and P1.1e8, respectively, when restricting the samples to individuals of EA with primary PD. In the Japanese sample no associations with PD could be found. The present results support the initial finding that TMEM132D gene contributes to genetic susceptibility for PD in individuals of EA. Our results also indicate that patient ascertainment and genetic background could be important sources of heterogeneity modifying this association signal in different populations.

AB - A recent genome-wide association study in patients with panic disorder (PD) identified a risk haplotype consisting of two single-nucleotide polymorphisms (SNPs) (rs7309727 and rs11060369) located in intron 3 of TMEM132D to be associated with PD in three independent samples. Now we report a subsequent confirmation study using five additional PD case-control samples (n1670 cases and n2266 controls) assembled as part of the Panic Disorder International Consortium (PanIC) study for a total of 2678 cases and 3262 controls in the analysis. In the new independent samples of European ancestry (EA), the association of rs7309727 and the risk haplotype rs7309727-rs11060369 was, indeed, replicated, with the strongest signal coming from patients with primary PD, that is, patients without major psychiatric comorbidities (n1038 cases and n2411 controls). This finding was paralleled by the results of the meta-analysis across all samples, in which the risk haplotype and rs7309727 reached P-levels of P1.4e8 and P1.1e8, respectively, when restricting the samples to individuals of EA with primary PD. In the Japanese sample no associations with PD could be found. The present results support the initial finding that TMEM132D gene contributes to genetic susceptibility for PD in individuals of EA. Our results also indicate that patient ascertainment and genetic background could be important sources of heterogeneity modifying this association signal in different populations.

UR - http://www.scopus.com/inward/record.url?scp=84866088924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866088924&partnerID=8YFLogxK

U2 - 10.1038/tp.2012.85

DO - 10.1038/tp.2012.85

M3 - Article

C2 - 22948381

AN - SCOPUS:84866088924

VL - 2

JO - Translational Psychiatry

JF - Translational Psychiatry

SN - 2158-3188

M1 - e156

ER -